維生素 B 群（綜合 B 群 / B-Complex） B-Complex Vitamins (B1, B2, B3/Niacin, B5, B6, B7/Biotin, B9/Folate, B12) × 認知功能 / 失智症預防
結論：主流反證據
raw score=U 但 L11 獨評 D / 建議 counter_evidence + 有 ≥1 efficacy-against (L5 against=3, L4 against=0, HEC=HEC-2) — 升 counter_evidence (B4-2 U-tier escalation)
U ⚫ U 未驗證 主流反證據 🚨 high — heavy affiliate marketing in TW community
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.24
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
U · 主流反證據
信心度
88%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.241
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 1 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial (VITACOG, Smith)
結論：Mean annual brain atrophy 0.76% with active B vitamins vs 1.08% with placebo (p=0.001); in the subgroup with baseline tHcy >13 micromol/L atrophy rate was 53% lower with active treatment (p=0.001).
前往 PubMed
Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial (VITACOG, de Jager)
結論：B vitamins stabilised executive function vs placebo (p=0.015); benefits on global cognition (p<0.001), episodic memory (p=0.001) and semantic memory (p=0.037) were confined to participants with baseline tHcy above the median (>11.3 micromol/L); CDR and IQCODE improved in the upper tHcy quartile (p=0.02 and p=0.01).
前往 PubMed
Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT (B-PROOF, van der Zwaluw)
結論：Plasma tHcy fell 5.0 vs 1.3 micromol/L (active vs placebo) but cognitive domain scores did not differ over 2 years; a marginal global-cognition signal (MMSE p=0.05) was attributed by the authors to chance.
前往 PubMed
The effect of vitamin B6 on cognition (Cochrane Review, Malouf & Grimley Evans)
結論：Despite biochemical improvement in B6 status, neither pooled trial showed any statistically significant benefit of vitamin B6 alone on mood or cognition; no evidence of short-term benefit.
前往 PubMed
Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals (Clarke, B-Vitamin Treatment Trialists' Collaboration)
結論：B-vitamin allocation lowered tHcy by ~25% but produced no significant effect on any individual cognitive domain, on global cognitive function, or on the rate of cognitive aging; a 25% tHcy reduction equated to only 0.02 years of cognitive aging per year of treatment, effectively excluding clinically meaningful slowing.
前往 PubMed
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: prespecified secondary analysis (VITATOPS, Hankey)
結論：tHcy lowered by B vitamins, but cognitive impairment incidence was identical (5.51% vs 5.47%; RR 1.01, p=0.976); no effect on cognitive decline (p=0.414) or combined outcome (p=0.855). An accompanying meta-analysis of trials enriched for stroke history was likewise null.
前往 PubMed
Vitamin B - Can it prevent cognitive decline? A systematic review and meta-analysis (Behrens)
結論：No significant overall effect on cognitive function (SMD 0.02, 95% CI -0.034 to 0.08; Z=0.87, p=0.39); occasional positive secondary outcomes were attributed to methodological heterogeneity.
前往 PubMed
Efficacy of B Vitamin Supplementation on Global Cognitive Function in Older Adults: A Systematic Review and Meta-analysis
結論：After excluding outliers and methodologically weak trials, GRADE high-certainty evidence indicates only a very small benefit of B6/B9/B12 supplementation on global cognition; clinically not meaningful and disappears in trim-and-fill sensitivity analyses.
前往 PubMed
L4a US FDA
支持
As part of a well-balanced diet, rich in fresh fruits and vegetables, daily intake of at least 400 mcg folic acid, 3 mg vitamin B6 and 5 mcg vitamin B12 may reduce the risk of vascular disease. 來源↗
L4b EU EFSA
支持
a cause and effect relationship has been established between the dietary intake of niacin and contribution to normal energy-yielding metabolism 來源↗
L4c UK NHS
謹慎
Taking 200mg or more a day of vitamin B6 can lead to a loss of feeling in the arms and legs known as peripheral neuropathy. ... Do not take more than 10mg of vitamin B6 a day in supplements unless advised to by a doctor. 來源↗
L4d TW TFDA / 衛福部
支持
目前公告之保健功效項目為：胃腸功能改善、調節血脂、護肝、骨質保健、免疫調節、輔助調整過敏體質、不易形成體脂肪、調節血糖、輔助調節血壓、抗疲勞、延緩衰老、輔助調節血鐵、牙齒保健、膝關節保健 來源↗
L4e WHO
謹慎
Vitamins B and E, PUFA and multi-complex supplementation should not be recommended to reduce the risk of cognitive decline and/or dementia. 來源↗
L5a NIH Office of Dietary Supplements
謹慎
B vitamins lower blood homocysteine concentrations, but several large clinical trials found that this reduction did not lower the risk of cardiovascular events. 來源↗
L5b Mayo Clinic
反對
Your diet is the best way to get the nutrients you need for your health 來源↗
L5c Cleveland Clinic
反對
Researchers have explored the link between cognition and vitamins B6, B9 and B12. But so far, there isn't evidence that B vitamins improve cognition or prevent dementia. 來源↗
L5d Harvard Health
謹慎
Although the research has shown that vitamin B12 supplementation reduces homocysteine blood levels, this has not translated into reduced rates of cognitive decline. A Cochrane review on folic acid supplements and cognition, with or without vitamin B12, did not find a significant effect of the supplements vs. placebo on cognitive function in healthy elderly people or people with dementia. 來源↗
L5e Specialty Society (condition-mapped)
反對
Not a single food, beverage, ingredient, vitamin or supplement has been proven to prevent, treat or cure Alzheimer's disease or to benefit cognitive function or brain health. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
台灣社群（PTT regimen/Health/love-vegetal、Mobile01 健康養生、Dcard 工作/美妝/男性保養）對 B 群討論量極大，但鄉民真實實測心得幾乎全集中在『提神、抗疲勞、嘴破改善、專注力、代謝』等可立即體感的主觀效果，並把『吃 B 群有醒腦感』直覺延伸為『對腦好/防退化』。針對『失智症預防/認知退化延緩』這個多年期硬指標，社群幾乎沒有第一手在地實測經驗（失智無法靠日常體感判斷），相關『B 群防失智、預防阿茲海默、降同半胱胺酸』論述絕大多數來自健康媒體（ETtoday、元氣網、台視）、醫療衛教（台大健教中心）與牛津研究轉述，而非匿名社群辯證。社群整體屬正面但偏題（談提神而非防失智），加上 B 群為台灣業配/affiliate 密度最高的保健品類之一，故 confidence 壓低。
💬社群實感
分歧／偏題（社群對 B 群『提神、專注、抗疲勞』多數正面有感，但這並非『失智症預防/認知退化延緩』；針對失智預防本身的在地實測心得幾近於無，因失智是多年期結果、無法靠日常體感判斷，相關防失智論述多來自健康媒體與醫療衛教而非鄉民經驗）
破解迷思 社群最常見的 5 個誤解
✓
事實把『吃 B 群有醒腦/提神感』直接等同於『B 群能預防失智、保護大腦不退化』（提神是即時主觀體感，失智預防是多年期硬指標，社群普遍混為一談）
✓
事實誤以為一般健康飲食者也能靠高劑量綜合 B 群『補腦防失智』（證據主要見於同半胱胺酸偏高或輕度認知障礙者，並非全民通用的失智預防神藥）
✓
事實誤以為『決醒對策/合利他命等 TTFD 醒腦型 B 群』因體感強就更能防失智（TTFD 主要訴求是提神持久，與認知退化預防的證據是兩回事）
✓
事實誤以為非活性 B 群（如氰鈷胺、葉酸）一定不如活性型（甲鈷胺、甲基葉酸），活性型才能護腦防失智（社群常見的活性 vs 非活性迷思，對多數人吸收差異被誇大）
✓
事實誤以為 B 群是水溶性『吃多無害、隨意補越多越防失智』，忽略長期高劑量 B6 反而可能造成周邊神經病變
🩹 社群通報的副作用
- 服用後尿液變黃（多歸因於 B2，社群普遍視為正常非不良反應）
- 空腹或高劑量服用後腸胃不適、噁心
- 部分人反映晚上吃太提神導致睡不著
- 少數提及皮膚過敏/起疹（個案）
- 社群偶有提醒長期高劑量 B6 恐造成手腳麻、周邊神經病變
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 決醒對策（TTFD 醒腦型，社群常被點名『記憶力/專注力提升較明顯』）
- 合利他命（Alinamin，老牌活性 B1 衍生物，疲勞恢復口碑高）
- 台塑生醫 B 群 EX PLUS（含 TTFD、牛磺酸）
- 克補 B 群＋鋅（平價開架，疲勞恢復用途）
- 萊萃美 Nature Made（Costco／開架通路，曝光高）
- DHC 維他命 B 群（平價日系，見效較慢）
- 國民酵母 B 群（天然食物來源訴求，多人推薦）
- NOW Foods／Jarrow（iHerb 代購，活性甲鈷胺/甲基葉酸選項）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 規律身體活動
- 高血壓的妥善控制
- 戒菸
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cognitive-function-INT-b-vitamins-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "維生素 B 群（綜合 B 群 / B-Complex）能改善認知功能 / 失智症預防",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"alternateName": "證據不足 (Insufficient evidence)"
}
}